Join Professor Peter Nash from the Griffith University in Brisbane, and Laura Coates, Professor at the University of Oxford’s Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, as they discuss a recent paper ‘Ixekizumab with tirzepatide achieved greater disease control than ixekizumab alone in adults with psoriatic arthritis and overweight or obesity: Results from a randomized clinical trial’.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The IMID Forum
Author Interview: Doctor Elise van Mulligen, September 2026
Discussing RA: Biologic effectiveness and treatment persistence in RA
Discussing PsA: Advances in Psoriatic Arthritis Management and Treatment Safety
Author Interview: Professor Axel Finckh and Associate Professor Bente Glintborg, August 2026
Get summaries like this every morning.
Free AI-powered recaps of The IMID Forum and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.